Demoxytocin: identity and limits of the evidence
Demoxytocin is a modified oxytocin analogue with uterine-contracting activity. It belongs in a discussion of specific hormone pharmacology and historical obstetric research, not a list of proven mood, bonding or anxiety supplements. Similarity to oxytocin does not make the two substances interchangeable in either a study or a product.
Identity and formulation
The NLM substance record identifies demoxytocin as a deamino analogue of oxytocin. A report must identify the actual analogue, formulation and route; an article that simply says “oxytocin” does not settle those details.
Historical buccal obstetric formulations and a laboratory powder have different identity, exposure and quality questions. A familiar hormone name cannot establish the contents or performance of an unverified preparation.
What the studies show
The directly identified historical clinical record concerns labour induction. Its PubMed entry has no abstract available for this review, so it cannot support a numerical efficacy or safety claim here. Research discussing oxytocin in psychiatric disorders supplies background on a related system; it does not establish a psychiatric benefit of demoxytocin.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Historical labour-induction report
Historical obstetric article; abstract unavailable Reading scope: PubMed bibliographic record; no abstract |
The indexed title identifies buccal oxytocin and demoxytocin in labour induction. | Only the bibliographic record was available; design, outcomes and risk estimates have not been verified. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
How to interpret the findings
The most useful first question is whether a source administered demoxytocin itself. A second question is whether it tested the outcome being advertised. Receptor similarity or a shared parent hormone cannot answer either question.
A modern, controlled study of a specified demoxytocin preparation would be needed to assess a new proposed indication. The historical obstetric record should not be stretched into a general claim about confidence, relationships or daily wellbeing.
Safety context
Uterine-contracting activity is a substantive pharmacological effect. It makes casual reproductive or pregnancy-related claims particularly inappropriate; a historical medical use is not evidence that unsupervised experimentation is safe.
Study exposure and units
This profile does not derive a personal regimen from obstetric literature or convert buccal exposure into an injectable amount. A concentration calculation would not resolve the missing indication-specific evidence.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Product identity and report checks
Check that the identity report explicitly distinguishes demoxytocin from oxytocin and identifies the formulation. A generic peptide assay, an oxytocin citation or a brand-name resemblance is not enough to make that distinction.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
Common questions
Is demoxytocin the same as oxytocin?
No. It is a related analogue. When evaluating a claim, check which molecule was actually administered, not merely whether the paper discusses the oxytocin system.
Does a mood study on oxytocin validate demoxytocin?
It does not. The intervention, route and clinical outcome must match. A review about a different hormone can provide background but cannot serve as a treatment trial of this analogue.
Sources
- NLM Demoxytocin substance record (PubChem identity and classification sections)
- Historical labour-induction report (PubMed bibliographic record; no abstract)